Correlation Between Bosch and Par Drugs

Can any of the company-specific risk be diversified away by investing in both Bosch and Par Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bosch and Par Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bosch Limited and Par Drugs And, you can compare the effects of market volatilities on Bosch and Par Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bosch with a short position of Par Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bosch and Par Drugs.

Diversification Opportunities for Bosch and Par Drugs

-0.21

Correlation Coefficient

Bosch  Par Drugs

Very good diversification

The 3 months correlation between Bosch and Par is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Bosch Limited and Par Drugs And in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Par Drugs And and Bosch is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bosch Limited are associated (or correlated) with Par Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Par Drugs And has no effect on the direction of Bosch i.e., Bosch and Par Drugs go up and down completely randomly.

Pair Corralation between Bosch and Par Drugs

Assuming the 90 days trading horizon Bosch is expected to generate 2.26 times less return on investment than Par Drugs. But when comparing it to its historical volatility, Bosch Limited is 2.34 times less risky than Par Drugs. It trades about 0.08 of its potential returns per unit of risk. Par Drugs And is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  24,920  in Par Drugs And on September 2, 2024 and sell it today you would earn a total of  4,120  from holding Par Drugs And or generate 16.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

Bosch Limited  vs.  Par Drugs And

Bosch Limited

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Bosch Limited are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain essential indicators, Bosch may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Par Drugs And

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Par Drugs And are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady technical and fundamental indicators, Par Drugs exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bosch and Par Drugs

The main advantage of trading using opposite Bosch and Par Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bosch position performs unexpectedly, Par Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Par Drugs will offset losses from the drop in Par Drugs' long position.

The idea behind Bosch Limited and Par Drugs And pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.